A PHASE II TRIAL WITH BEVACIZUMAB AND IRINOTECAN FOR PATIENTS WITH PRIMARY BRAIN TUMORS AND PROGRESSION AFTER STANDARD THERAPY

被引：0
|
作者：
Moller, Soren [1 ]
Grunnet, Kirsten [1 ]
Hansen, Steinbjorn [2 ]
Schultz, Henrik [3 ]
Holmberg, Mats [4 ]
Sorensen, Morten M. [1 ]
Poulsen, Hans S. [1 ]
Lassen, Ulrik [1 ]
机构：
[1] Rigshosp, Copenhagen Univ Hosp, Copenhagen, Denmark
[2] Odense Univ Hosp, Odense, Denmark
[3] Aarhus Univ Hosp, Aarhus, Denmark
[4] Aalborg Univ Hosp, Aalborg, Denmark
来源：
NEURO-ONCOLOGY | 2010年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：73 / 73
页数：1
相关论文
共 50 条
  • [31] Phase II trial of carboplatin and bevacizumab in patients with breast cancer brain metastases
    Jose Pablo Leone
    Kyrre E. Emblem
    Michelle Weitz
    Rebecca S. Gelman
    Bryan P. Schneider
    Rachel A. Freedman
    Jerry Younger
    Marco C. Pinho
    A. Gregory Sorensen
    Elizabeth R. Gerstner
    Gordon Harris
    Ian E. Krop
    Daniel Morganstern
    Jessica Sohl
    Jiani Hu
    Elizabeth Kasparian
    Eric P. Winer
    Nancy U. Lin
    Breast Cancer Research, 22
  • [32] Phase II trial of carboplatin and bevacizumab in patients with breast cancer brain metastases
    Leone, Jose Pablo
    Emblem, Kyrre E.
    Weitz, Michelle
    Gelman, Rebecca S.
    Schneider, Bryan P.
    Freedman, Rachel A.
    Younger, Jerry
    Pinho, Marco C.
    Sorensen, A. Gregory
    Gerstner, Elizabeth R.
    Harris, Gordon
    Krop, Ian E.
    Morganstern, Daniel
    Sohl, Jessica
    Hu, Jiani
    Kasparian, Elizabeth
    Winer, Eric P.
    Lin, Nancy U.
    BREAST CANCER RESEARCH, 2020, 22 (01)
  • [33] Phase II Trial of Bevacizumab Monotherapy in Pancreatic Neuroendocrine Tumors
    Zhu, Mojun
    Costello, Brian A.
    Yin, Jun
    Pettinger, Adam M.
    Strosberg, Jonathan R.
    Erlichman, Charles
    Hobday, Timothy J.
    PANCREAS, 2021, 50 (10) : 1435 - 1439
  • [34] A phase II trial of atezolizumab and bevacizumab in patients with advanced, progressive neuroendocrine tumors (NETs)
    Halperin, Daniel M.
    Liu, Suyu
    Dasari, Arvind
    Fogelman, David R.
    Bhosale, Priya
    Mahvash, Armeen
    Dervin, Shannon
    Estrella, Jeannelyn
    Cortazar, Patricia
    Maru, Dipen M.
    Mckenna, Edward Francis
    Wistuba, Ignacio Ivan
    Schulze, Katja
    Futreal, Phillip Andrew
    Darbonne, Walter C.
    Yun, Cindy
    Hwu, Patrick
    Yao, James C.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [35] Phase II trial of sunitinib in patients with metastatic colorectal cancer after failure of standard therapy
    Saltz, Leonard B.
    Rosen, Lee S.
    Marshall, John L.
    Belt, Robert J.
    Hurwitz, Herbert I.
    Eckhardt, S. Gail
    Bergsland, Emily K.
    Haller, Daniel G.
    Lockhart, A. Craig
    Lima, Caio M. Rocha
    Huang, Xin
    DePrimo, Samuel E.
    Chow-Maneval, Edna
    Chao, Richard C.
    Lenz, Heinz J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (30) : 4793 - 4799
  • [36] PHASE-II TRIAL OF MITOGAUZONE IN MALIGNANT PRIMARY BRAIN-TUMORS
    FEUN, LG
    YUNG, WKA
    STEWART, DJ
    SAVARAJ, N
    BODEY, GP
    CANCER TREATMENT REPORTS, 1985, 69 (03): : 329 - 330
  • [37] Irinotecan and gemcitabine in patients with solid tumors: Phase I trial
    Lima, CMSR
    Leong, SS
    Sherman, CA
    Perkel, JA
    Putman, T
    Safa, AR
    Green, MR
    ONCOLOGY-NEW YORK, 2002, 16 (05): : 19 - 24
  • [38] PHASE II TRIAL OF COMBINED CHEMOTHERAPY WITH IRINOTECAN, S-1, AND BEVACIZUMAB IN PATIENTS WITH METASTATIC COLORECTAL CANCER
    Komatsu, Y.
    Yuki, S.
    Sogabe, S.
    Nakamura, M.
    Hatanaka, K.
    Miyagishima, T.
    Kudo, M.
    Munakata, M.
    Sakata, Y.
    Asaka, M.
    ANNALS OF ONCOLOGY, 2010, 21 : 197 - 197
  • [39] Phase II trial of irinotecan, carboplatin, and bevacizumab in patients with limited-stage small cell lung cancer
    Zubkus, J. D.
    Spigel, D. R.
    Greco, F. A.
    Yardley, D. A.
    Burris, H. A., III
    Vazquez, E.
    Farley, C.
    Patton, J. F.
    Hart, L.
    Hainsworth, J. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [40] Phase II trial of combined chemotherapy with irinotecan, S-1, and bevacizumab in patients with metastatic colorectal cancer
    Hatanaka, K.
    Komatsu, Y.
    Yuki, S.
    Nakamura, M.
    Miyagishima, T.
    Kudo, M.
    Munakata, M.
    Sakata, Y.
    Asaka, M.
    EJC SUPPLEMENTS, 2009, 7 (02): : 336 - 336
12345